Abstract 14181: Poor Long-Term Prognosis in Patients With Inflammatory Dilated Cardiomyopathy Diagnosed by Immunohistochemistry-Based Criteria
Yasuo Sugano(keiyu Hospital), Toshihisa Anzai(Hokkaido University), Hisao Ogawa(Kumamoto University Hospital), Takafumi Nakayama(National Cerebral and Cardiovascular Center), Satoshi Yasuda(Tohoku University), Keiko Ogo(National Cerebral and Cardiovascular Center), Tetsuro Yokokawa(Fukushima Medical University), Yoshihiko Ikeda(National Cerebral and Cardiovascular Center), Takeshi Nakatani(National Cerebral and Cardiovascular Center), Toshiyuki Nagai(Hokkaido University)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755